Published in Adv Immunol on January 01, 2001
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci U S A (2006) 2.51
Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). J Immunol Methods (2007) 1.36
The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb Cell Fact (2003) 1.07
Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains. Structure (2013) 1.01
Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids. Clin Diagn Lab Immunol (2005) 1.00
Natural and man-made V-gene repertoires for antibody discovery. Front Immunol (2012) 0.98
Nanobodies as novel agents for disease diagnosis and therapy. Int J Nanomedicine (2013) 0.93
Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier. Br J Pharmacol (2012) 0.87
Generation of heavy-chain-only antibodies in mice. Proc Natl Acad Sci U S A (2006) 0.86
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer. Expert Opin Drug Deliv (2014) 0.85
Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains. BMC Biotechnol (2007) 0.84
Heavy-chain only antibodies derived from dromedary are secreted and displayed by mouse B cells. Immunology (2003) 0.83
Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function. J Biol Chem (2013) 0.83
Nanobody(R)-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sites. Nucleic Acids Res (2012) 0.81
Functional inhibition of β-catenin-mediated Wnt signaling by intracellular VHH antibodies. MAbs (2015) 0.80
Fingerprint-like Analysis of "Nanoantibody" Selection by Phage Display Using Two Helper Phage Variants. Acta Naturae (2010) 0.79
Affinity is an important determinant of the anti-trypanosome activity of nanobodies. PLoS Negl Trop Dis (2012) 0.79
A novel VHH antibody targeting the B cell-activating factor for B-cell lymphoma. Int J Mol Sci (2014) 0.78
Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting. Acta Naturae (2014) 0.76
Molecular imprint of enzyme active site by camel nanobodies: rapid and efficient approach to produce abzymes with alliinase activity. J Biol Chem (2012) 0.76
A new approach to study cellular components associated with a certain protein. Dokl Biochem Biophys (2008) 0.75
Naturally occurring antibodies devoid of light chains. Nature (1993) 7.35
Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett (1997) 3.18
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat Struct Biol (1996) 2.54
Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J (1998) 2.30
Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother (2001) 2.24
Comparison of llama VH sequences from conventional and heavy chain antibodies. Mol Immunol (1998) 1.67
Position and orientation of the globular domain of linker histone H5 on the nucleosome. Nature (1998) 1.62
Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J Biol Chem (2000) 1.38
A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. Structure (1999) 1.36
Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire. EMBO J (2000) 1.28
Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate. Proteins (1998) 1.26
Homo- and heteronuclear two-dimensional NMR studies of the globular domain of histone H1: full assignment, tertiary structure, and comparison with the globular domain of histone H5. Biochemistry (1994) 1.20
Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. J Biol Chem (2001) 1.15
Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes? J Mol Biol (2000) 1.08
The specific variable domain of camel heavy-chain antibodies is encoded in the germline. J Mol Biol (1998) 1.02
Degenerate interfaces in antigen-antibody complexes. J Mol Biol (2001) 1.02
The piglet as a model for B cell and immune system development. Vet Immunol Immunopathol (2008) 1.02
The essential catalytic redox couple in arsenate reductase from Staphylococcus aureus. Biochemistry (1999) 1.00
Emergence and evolution of functional heavy-chain antibodies in Camelidae. Dev Comp Immunol (2003) 1.00
Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies. Mol Immunol (1999) 0.99
Homo- and heteronuclear two-dimensional NMR studies of the globular domain of histone H1: sequential assignment and secondary structure. Biochemistry (1993) 0.98
Formation, stability and core histone positioning of nucleosomes reassembled on bent and other nucleosome-derived DNA. J Mol Biol (1989) 0.96
Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis. Int J Parasitol (2008) 0.92
[Phenotypic and genotypic properties of 4 virulence plasmids of Salmonella typhimurium]. Ann Inst Pasteur Microbiol (1988) 0.92
Different residues in periplasmic domains of the CcmC inner membrane protein of Pseudomonas fluorescens ATCC 17400 are critical for cytochrome c biogenesis and pyoverdine-mediated iron uptake. Mol Microbiol (1998) 0.91
Single domain antibodies: comparison of camel VH and camelised human VH domains. J Immunol Methods (1999) 0.89
Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier. Br J Pharmacol (2012) 0.87
Construction in vitro of "phage-plasmid" chimerae: a new tool to analyse the mechanism of plasmid maintenance. Mol Gen Genet (1979) 0.87
Mini-F E protein: the carboxy-terminal end is essential for E gene repression and mini-F copy number control. J Mol Biol (1986) 0.86
Neutron scattering studies of chromatosomes. Biochem Biophys Res Commun (1991) 0.86
Histone H1 can be removed selectively from chicken erythrocyte chromatin at near physiological conditions. Nucleic Acids Res (1980) 0.86
Differences in rearrangements of H1 and H5 in chicken erythrocyte chromatin. Biochemistry (1981) 0.86
DNA recombination associated with short direct repeats in Leishmania mexicana M379. Mol Biochem Parasitol (1992) 0.85
Upon the observation of superbeads in chromatin. Nucleic Acids Res (1980) 0.84
The interaction of histone H5 and its globular domain with core particles, depleted chromatosomes, polynucleosomes, and a DNA decamer. J Biol Chem (1991) 0.84
Comparative filter binding study of H5 to nucleosome core particles, H1, H5 depleted chromatosomes and DNA fragments. Mol Biol Rep (1990) 0.82
Chaperonin GroEL a Brucella immunodominant antigen identified using Nanobody and MALDI-TOF-MS technologies. Vet Immunol Immunopathol (2012) 0.82
Chromosome rearrangement in Leishmania mexicana M379. Mol Biochem Parasitol (1991) 0.80
Putative regulatory sequences for the transcription of mini-exons in Trypanosoma brucei as revealed by S1 sensitivity. Gene (1985) 0.79
Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor. J Thromb Haemost (2010) 0.79
Scatter analysis of discrete-sized chromatin fragments favours a cylindrical organization. Eur J Biochem (1985) 0.79
Protection of discrete DNA fragments by the complex H1-octamerhistones or H5-octamerhistones after micrococcal nuclease digestion. Nucleic Acids Res (1981) 0.79
Evaluation of a nanobody phage display library constructed from a Brucella-immunised camel. Vet Immunol Immunopathol (2011) 0.79
Resolution of an immunodiagnostic dilemma: heavy chain chimeric antibodies for species in which plasmocytomas are unknown. Mol Immunol (2012) 0.79
Preparation and purification of mononucleosome particles containing histone H5. FEBS Lett (1980) 0.78
Inversion and deletion mutants in Bacillus subtilis bacteriophage SPP1 as a consequence of cloning. Mol Gen Genet (1985) 0.78
Assembly of oligonucleosomes into a limit series of multimeric higher-order chromatin structures. Eur J Biochem (1985) 0.78
Limitations of the poly(glutamic acid) reconstitution method in the reassembly of mono- and dinucleosomes. Biochemistry (1986) 0.77
The structural organization of dinucleosomes and oligonucleosomes. Electric dichroism and birefringence study. Nucleic Acids Res (1981) 0.77
Identification of a novel, nanobody-induced, mechanism of TAFI inactivation and its in vivo application. J Thromb Haemost (2014) 0.77
TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation. J Thromb Haemost (2011) 0.77
Molecular analysis of heavy chain-only antibodies of Camelus bactrianus. Biochemistry (Mosc) (2014) 0.76
The regulated expression of an intrabody produces a mutant phenotype in Drosophila. FEBS Lett (1998) 0.75
Preparation and behaviour of H1-depleted, H5-containing chicken erythrocyte chromatin [proceedings]. Arch Int Physiol Biochim (1980) 0.75
Isolation and characterization of single-chain Fv genes encoding antibodies specific for Drosophila Poxn protein. FEBS Lett (1998) 0.75
Primary hyperparathyroidism and monoclonal gammopathy in a dog. J Vet Intern Med (2009) 0.75
The crystal structure of recombinant rat pancreatic RNase A. Proteins (1999) 0.75